{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T23:51:09Z","timestamp":1781049069726,"version":"3.54.1"},"reference-count":170,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Immunology"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.clim.2025.110574","type":"journal-article","created":{"date-parts":[[2025,7,26]],"date-time":"2025-07-26T15:02:54Z","timestamp":1753542174000},"page":"110574","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["The role of signaling lymphocytic activation molecule (SLAM) family receptors in health and disease progression: Focusing on cancer and therapy"],"prefix":"10.1016","volume":"280","author":[{"given":"Guhan","family":"Luo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuanwei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanhui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dingcun","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clim.2025.110574_bb0005","first-page":"52","article-title":"Role of the TME in immune checkpoint blockade resistance of non-small cell lung cancer","volume":"7","author":"Dai","year":"2024","journal-title":"Cancer Drug Resist."},{"key":"10.1016\/j.clim.2025.110574_bb0010","doi-asserted-by":"crossref","first-page":"5999","DOI":"10.62347\/FFXL7288","article-title":"The role and research progress of tumor-associated macrophages in cervical cancer","volume":"14","author":"Wang","year":"2024","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.clim.2025.110574_bb0015","doi-asserted-by":"crossref","first-page":"1174138","DOI":"10.3389\/fimmu.2023.1174138","article-title":"SLAM-family receptors come of age as a potential molecular target in cancer immunotherapy","volume":"14","author":"Farhangnia","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.clim.2025.110574_bb0020","doi-asserted-by":"crossref","DOI":"10.1007\/s12094-024-03675-2","article-title":"SLAM family-mediated crosstalk between tumor and immune cells in the tumor microenvironment: a promising biomarker and a potential therapeutic target for immune checkpoint therapies","author":"Kwantwi","year":"2024","journal-title":"Clin. Transl. Oncol."},{"key":"10.1016\/j.clim.2025.110574_bb0025","doi-asserted-by":"crossref","first-page":"1297473","DOI":"10.3389\/fimmu.2024.1297473","article-title":"Signaling lymphocytic activation molecule family receptors as potential immune therapeutic targets in solid tumors","volume":"15","author":"Gunes","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.clim.2025.110574_bb0030","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/nm1189","article-title":"Regulation of NKT cell development by SAP, the protein defective in XLP","volume":"11","author":"Nichols","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.clim.2025.110574_bb0035","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0065-2776(08)00004-7","article-title":"The SLAM and SAP gene families control innate and adaptive immune responses","volume":"97","author":"Calpe","year":"2008","journal-title":"Adv. Immunol."},{"key":"10.1016\/j.clim.2025.110574_bb0040","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s00281-009-0193-0","article-title":"SLAM family receptors and the SLAM-associated protein (SAP) modulate T cell functions","volume":"32","author":"Detre","year":"2010","journal-title":"Semin. Immunopathol."},{"key":"10.1016\/j.clim.2025.110574_bb0045","article-title":"Suppression of adaptive NK cell expansion by macrophage-mediated phagocytosis inhibited by 2B4-CD48","volume":"43","author":"Li","year":"2024","journal-title":"Cell Rep."},{"key":"10.1016\/j.clim.2025.110574_bb0050","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3389\/fimmu.2013.00003","article-title":"NK cell cytotoxicity mediated by 2B4 and NTB-A is dependent on SAP acting downstream of receptor phosphorylation","volume":"4","author":"Meinke","year":"2013","journal-title":"Front. Immunol."},{"key":"10.1016\/j.clim.2025.110574_bb0055","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1158\/0008-5472.CAN-23-3106","article-title":"Repolarization of immunosuppressive macrophages by targeting SLAMF7-regulated CCL2 signaling sensitizes hepatocellular carcinoma to immunotherapy","volume":"84","author":"Weng","year":"2024","journal-title":"Cancer Res."},{"key":"10.1016\/j.clim.2025.110574_bb0060","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/ni0103-19","article-title":"The dual-function CD150 receptor subfamily: the viral attraction","volume":"4","author":"Sidorenko","year":"2003","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.clim.2025.110574_bb0065","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1146\/annurev.immunol.25.022106.141651","article-title":"Regulation of cellular and humoral immune responses by the SLAM and SAP families of molecules","volume":"25","author":"Ma","year":"2007","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.clim.2025.110574_bb0070","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/nri2456","article-title":"SLAM receptors and SAP influence lymphocyte interactions, development and function","volume":"9","author":"Schwartzberg","year":"2009","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.clim.2025.110574_bb0075","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1586\/17474086.2015.1053866","article-title":"Preclinical and clinical evaluation of elotuzumab, a SLAMF7-targeted humanized monoclonal antibody in development for multiple myeloma","volume":"8","author":"Palumbo","year":"2015","journal-title":"Expert Rev. Hematol."},{"key":"10.1016\/j.clim.2025.110574_bb0080","first-page":"47","article-title":"Cancer incidence and mortality in China, 2022","volume":"4","author":"Han","year":"2024","journal-title":"J. Natl. Cancer Cent."},{"key":"10.1016\/j.clim.2025.110574_bb0085","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a002469","article-title":"SLAM-family receptors: immune regulators with or without SAP-family adaptors","volume":"2","author":"Veillette","year":"2010","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.clim.2025.110574_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.112088","article-title":"A review: mechanisms and molecular pathways of signaling lymphocytic activation molecule family 3 (SLAMF3) in immune modulation and therapeutic prospects","volume":"133","author":"Zhou","year":"2024","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.clim.2025.110574_bb0095","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.coi.2015.11.003","article-title":"SLAM family receptors in normal immunity and immune pathologies","volume":"38","author":"Wu","year":"2016","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.clim.2025.110574_bb0100","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13020279","article-title":"Immune functions of signaling lymphocytic activation molecule family molecules in multiple myeloma","volume":"13","author":"Ishibashi","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.clim.2025.110574_bb0105","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25074014","article-title":"SLAM family receptors in B cell chronic lymphoproliferative disorders","volume":"25","author":"K\u013eoc","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.clim.2025.110574_bb0110","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1007\/s00251-001-0415-7","article-title":"Identification and characterization of SF2000 and SF2001, two new members of the immune receptor SLAM\/CD2 family","volume":"53","author":"Fraser","year":"2002","journal-title":"Immunogenetics"},{"key":"10.1016\/j.clim.2025.110574_bb0115","doi-asserted-by":"crossref","first-page":"5809","DOI":"10.4049\/jimmunol.161.11.5809","article-title":"Identification of the 2B4 molecule as a counter-receptor for CD48","volume":"161","author":"Latchman","year":"1998","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2025.110574_bb0120","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.immuni.2007.08.019","article-title":"Structure of natural killer receptor 2B4 bound to CD48 reveals basis for heterophilic recognition in signaling lymphocyte activation molecule family","volume":"27","author":"Velikovsky","year":"2007","journal-title":"Immunity"},{"key":"10.1016\/j.clim.2025.110574_bb0125","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1084\/jem.188.11.2083","article-title":"2B4, the natural killer and T cell immunoglobulin superfamily surface protein, is a ligand for CD48","volume":"188","author":"Brown","year":"1998","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.clim.2025.110574_bb0130","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1146\/annurev-immunol-030409-101302","article-title":"SLAM family receptors and SAP adaptors in immunity","volume":"29","author":"Cannons","year":"2011","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.clim.2025.110574_bb0135","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.it.2010.05.008","article-title":"How do SAP family deficiencies compromise immunity?","volume":"31","author":"Dong","year":"2010","journal-title":"Trends Immunol."},{"key":"10.1016\/j.clim.2025.110574_bb0140","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/eji.200636341","article-title":"Modulation of 2B4 (CD244) activity and regulated SAP expression in human NK cells","volume":"37","author":"Endt","year":"2007","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.clim.2025.110574_bb0145","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1084\/jem.20132038","article-title":"EAT-2, a SAP-like adaptor, controls NK cell activation through phospholipase C\u03b3, Ca++, and Erk, leading to granule polarization","volume":"211","author":"P\u00e9rez-Quintero","year":"2014","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.clim.2025.110574_bb0150","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/j.immuni.2012.03.023","article-title":"The adaptor SAP controls NK cell activation by regulating the enzymes Vav-1 and SHIP-1 and by enhancing conjugates with target cells","volume":"36","author":"Dong","year":"2012","journal-title":"Immunity"},{"key":"10.1016\/j.clim.2025.110574_bb0155","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/nri1202","article-title":"The SAP and SLAM families in immune responses and X-linked lymphoproliferative disease","volume":"3","author":"Engel","year":"2003","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.clim.2025.110574_bb0160","doi-asserted-by":"crossref","first-page":"4623","DOI":"10.4049\/jimmunol.1500552","article-title":"Identification of the SLAM adapter molecule EAT-2 as a lupus-susceptibility gene that acts through impaired negative regulation of dendritic cell signaling","volume":"195","author":"Talaei","year":"2015","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2025.110574_bb0165","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.clim.2018.10.015","article-title":"SLAMF1\/CD150 in hematologic malignancies: silent marker or active player?","volume":"204","author":"Gordiienko","year":"2019","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.clim.2025.110574_bb0170","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.clim.2018.10.013","article-title":"SLAMF6 in health and disease: Implications for therapeutic targeting","volume":"204","author":"Yigit","year":"2019","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.clim.2025.110574_bb0175","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/ncb920","article-title":"SAP couples Fyn to SLAM immune receptors","volume":"5","author":"Chan","year":"2003","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.clim.2025.110574_bb0180","doi-asserted-by":"crossref","first-page":"5559","DOI":"10.1128\/MCB.00357-06","article-title":"Association between SAP and FynT: inducible SH3 domain-mediated interaction controlled by engagement of the SLAM receptor","volume":"26","author":"Chen","year":"2006","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.clim.2025.110574_bb0185","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1038\/90615","article-title":"Regulation of SLAM-mediated signal transduction by SAP, the X-linked lymphoproliferative gene product","volume":"2","author":"Latour","year":"2001","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.clim.2025.110574_bb0190","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1177\/0961203315584412","article-title":"Analysis of expression and function of the co-stimulatory receptor SLAMF1 in immune cells from patients with systemic lupus erythematosus (SLE)","volume":"24","author":"Li\u00f1\u00e1n-Rico","year":"2015","journal-title":"Lupus"},{"key":"10.1016\/j.clim.2025.110574_bb0195","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1083\/jcb.201707027","article-title":"SLAMF1 is required for TLR4-mediated TRAM-TRIF-dependent signaling in human macrophages","volume":"217","author":"Yurchenko","year":"2018","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.clim.2025.110574_bb0200","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1038\/ni.1931","article-title":"SLAM is a microbial sensor that regulates bacterial phagosome functions in macrophages","volume":"11","author":"Berger","year":"2010","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.clim.2025.110574_bb0205","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1084\/jem.20031835","article-title":"The cell surface receptor SLAM controls T cell and macrophage functions","volume":"199","author":"Wang","year":"2004","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.clim.2025.110574_bb0210","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/nri1761","article-title":"Immune regulation by SLAM family receptors and SAP-related adaptors","volume":"6","author":"Veillette","year":"2006","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.clim.2025.110574_bb0215","doi-asserted-by":"crossref","first-page":"29309","DOI":"10.1074\/jbc.M601314200","article-title":"Crystal structure and binding properties of the CD2 and CD244 (2B4)-binding protein, CD48","volume":"281","author":"Evans","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.clim.2025.110574_bb0220","article-title":"SLAM family receptor signaling in viral infections: HIV and beyond","volume":"7","author":"O\u2019Connell","year":"2019","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.clim.2025.110574_bb0225","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1034\/j.1600-065X.2001.1810120.x","article-title":"2B4 (CD244) and CS1: novel members of the CD2 subset of the immunoglobulin superfamily molecules expressed on natural killer cells and other leukocytes","volume":"181","author":"Boles","year":"2001","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.clim.2025.110574_bb0230","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.1600-065X.2006.00453.x","article-title":"NK cell regulation by SLAM family receptors and SAP-related adapters","volume":"214","author":"Veillette","year":"2006","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.clim.2025.110574_bb0235","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1159\/000345121","article-title":"Enhancement of antigen-specific immunoglobulin G responses by anti-CD48","volume":"5","author":"Yuan","year":"2013","journal-title":"J. Innate Immun."},{"key":"10.1016\/j.clim.2025.110574_bb0240","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1006\/cimm.1996.0297","article-title":"CD48 delivers an accessory signal for CD40-mediated activation of human B cells","volume":"174","author":"Klyushnenkova","year":"1996","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.clim.2025.110574_bb0245","doi-asserted-by":"crossref","first-page":"4436","DOI":"10.4049\/jimmunol.1302909","article-title":"Engagement of SLAMF2\/CD48 prolongs the time frame of effective T cell activation by supporting mature dendritic cell survival","volume":"192","author":"Kis-Toth","year":"2014","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2025.110574_bb0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.111282","article-title":"SLAMF3 promotes Th17 differentiation and is reversed by iguratimod through JAK1\/STAT3 pathway in primary Sj\u00f6gren\u2019s syndrome","volume":"126","author":"Hu","year":"2024","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.clim.2025.110574_bb0255","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.4049\/jimmunol.1102773","article-title":"Increased expression of SLAM receptors SLAMF3 and SLAMF6 in systemic lupus erythematosus T lymphocytes promotes Th17 differentiation","volume":"188","author":"Chatterjee","year":"2012","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2025.110574_bb0260","doi-asserted-by":"crossref","first-page":"38168","DOI":"10.1074\/jbc.M112.415067","article-title":"CD3-T cell receptor co-stimulation through SLAMF3 and SLAMF6 receptors enhances ROR\u03b3t recruitment to the IL17A promoter in human T lymphocytes","volume":"287","author":"Chatterjee","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.clim.2025.110574_bb0265","doi-asserted-by":"crossref","first-page":"9321","DOI":"10.1073\/pnas.1605081113","article-title":"Engagement of SLAMF3 enhances CD4+ T-cell sensitivity to IL-2 and favors regulatory T-cell polarization in systemic lupus erythematosus","volume":"113","author":"Comte","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.clim.2025.110574_bb0270","doi-asserted-by":"crossref","first-page":"5056","DOI":"10.1038\/s41467-024-49466-9","article-title":"SLAM-family receptors promote resolution of ILC2-mediated inflammation","volume":"15","author":"Wang","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.clim.2025.110574_bb0275","doi-asserted-by":"crossref","first-page":"831","DOI":"10.3389\/fimmu.2019.00831","article-title":"The checkpoint regulator SLAMF3 preferentially prevents expansion of auto-reactive B cells generated by graft-vs.-host disease","volume":"10","author":"Wang","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.clim.2025.110574_bb0280","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1084\/jem.20151722","article-title":"IFN-\u03b3 receptor and STAT1 signaling in B cells are central to spontaneous germinal center formation and autoimmunity","volume":"213","author":"Domeier","year":"2016","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.clim.2025.110574_bb0285","article-title":"Advances in understanding the roles of CD244 (SLAMF4) in immune regulation and associated diseases","volume":"12","author":"Sun","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.clim.2025.110574_bb0290","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.clim.2018.10.009","article-title":"2B4 (CD244, SLAMF4) and CS1 (CD319, SLAMF7) in systemic lupus erythematosus and cancer","volume":"204","author":"Malaer","year":"2019","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.clim.2025.110574_bb0295","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1172\/JCI41264","article-title":"Absence of mouse 2B4 promotes NK cell-mediated killing of activated CD8+ T cells, leading to prolonged viral persistence and altered pathogenesis","volume":"120","author":"Waggoner","year":"2010","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.clim.2025.110574_bb0300","doi-asserted-by":"crossref","first-page":"377","DOI":"10.3389\/fimmu.2012.00377","article-title":"Evolving role of 2B4\/CD244 in T and NK cell responses during virus infection","volume":"3","author":"Waggoner","year":"2012","journal-title":"Front. Immunol."},{"key":"10.1016\/j.clim.2025.110574_bb0305","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1002\/eji.200424886","article-title":"Homophilic interaction of NTBA, a member of the CD2 molecular family: induction of cytotoxicity and cytokine release in human NK cells","volume":"34","author":"Falco","year":"2004","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.clim.2025.110574_bb0310","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1038\/s41467-021-22230-z","article-title":"The survival and function of IL-10-producing regulatory B cells are negatively controlled by SLAMF5","volume":"12","author":"Radomir","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.clim.2025.110574_bb0315","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.clim.2018.10.017","article-title":"CD84 cell surface signaling molecule: an emerging biomarker and target for cancer and autoimmune disorders","volume":"204","author":"Cuenca","year":"2019","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.clim.2025.110574_bb0320","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.immuni.2010.01.010","article-title":"Optimal germinal center responses require a multistage T cell:B cell adhesion process involving integrins, SLAM-associated protein, and CD84","volume":"32","author":"Cannons","year":"2010","journal-title":"Immunity"},{"key":"10.1016\/j.clim.2025.110574_bb0325","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/nature20810","article-title":"Pathologically expanded peripheral T helper cell subset drives B cells in rheumatoid arthritis","volume":"542","author":"Rao","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.clim.2025.110574_bb0330","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.4049\/jimmunol.1202145","article-title":"A role for Ly108 in the induction of promyelocytic zinc finger transcription factor in developing thymocytes","volume":"190","author":"Dutta","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2025.110574_bb0335","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1158\/2326-6066.CIR-17-0383","article-title":"Soluble SLAMF6 receptor induces strong CD8(+) T-cell effector function and improves anti-melanoma activity in vivo","volume":"6","author":"Eisenberg","year":"2018","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.clim.2025.110574_bb0340","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/s41590-019-0334-0","article-title":"SLAM receptors foster iNKT cell development by reducing TCR signal strength after positive selection","volume":"20","author":"Lu","year":"2019","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.clim.2025.110574_bb0345","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.52539","article-title":"SLAMF6 deficiency augments tumor killing and skews toward an effector phenotype revealing it as a novel T cell checkpoint","volume":"9","author":"Hajaj","year":"2020","journal-title":"Elife"},{"key":"10.1016\/j.clim.2025.110574_bb0350","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/ni.3369","article-title":"A hematopoietic cell-driven mechanism involving SLAMF6 receptor, SAP adaptors and SHP-1 phosphatase regulates NK cell education","volume":"17","author":"Wu","year":"2016","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.clim.2025.110574_bb0355","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.immuni.2007.08.020","article-title":"Homotypic interactions mediated by Slamf1 and Slamf6 receptors control NKT cell lineage development","volume":"27","author":"Griewank","year":"2007","journal-title":"Immunity"},{"key":"10.1016\/j.clim.2025.110574_bb0360","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.immuni.2012.05.016","article-title":"The receptor Ly108 functions as a SAP adaptor-dependent on-off switch for T cell help to B cells and NKT cell development","volume":"36","author":"Kageyama","year":"2012","journal-title":"Immunity"},{"key":"10.1016\/j.clim.2025.110574_bb0365","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2017.1339853","article-title":"The anti-SLAMF7 antibody elotuzumab mediates NK cell activation through both CD16-dependent and -independent mechanisms","volume":"6","author":"Pazina","year":"2017","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.clim.2025.110574_bb0370","doi-asserted-by":"crossref","first-page":"193","DOI":"10.4049\/jimmunol.2000300","article-title":"SLAMF7 signaling reprograms T cells toward exhaustion in the tumor microenvironment","volume":"206","author":"O\u2019Connell","year":"2021","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2025.110574_bb0375","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abf2846","article-title":"SLAMF7 engagement superactivates macrophages in acute and chronic inflammation","volume":"7","author":"Simmons","year":"2022","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.clim.2025.110574_bb0380","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/nature22076","article-title":"SLAMF7 is critical for phagocytosis of haematopoietic tumour cells via Mac-1 integrin","volume":"544","author":"Chen","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.clim.2025.110574_bb0385","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.tcb.2004.10.005","article-title":"Integrins: versatile integrators of extracellular signals","volume":"14","author":"ffrench-Constant, C. & Colognato, H","year":"2004","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.clim.2025.110574_bb0390","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.846695","article-title":"SLAMF8 participates in acute renal transplant rejection via TLR4 pathway on pro-inflammatory macrophages","volume":"13","author":"Teng","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.clim.2025.110574_bb0395","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/s41423-018-0191-z","article-title":"Combined deficiency of SLAMF8 and SLAMF9 prevents endotoxin-induced liver inflammation by downregulating TLR4 expression on macrophages","volume":"17","author":"Zeng","year":"2020","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.clim.2025.110574_bb0400","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1038\/s41598-020-59530-1","article-title":"SLAM family member 8 is expressed in and enhances the growth of anaplastic large cell lymphoma","volume":"10","author":"Sugimoto","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.clim.2025.110574_bb0405","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2023.101654","article-title":"SLAMF8, a potential new immune checkpoint molecule, is associated with the prognosis of colorectal cancer","volume":"31","author":"Zhang","year":"2023","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.clim.2025.110574_bb0410","doi-asserted-by":"crossref","DOI":"10.1002\/cti2.1347","article-title":"SLAMF8 expression predicts the efficacy of anti-PD1 immunotherapy in gastrointestinal cancers","volume":"10","author":"Zhang","year":"2021","journal-title":"Clin. Transl. Immunol."},{"key":"10.1016\/j.clim.2025.110574_bb0415","doi-asserted-by":"crossref","first-page":"16489","DOI":"10.1073\/pnas.1900079116","article-title":"SLAMF9 regulates pDC homeostasis and function in health and disease","volume":"116","author":"Sever","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.clim.2025.110574_bb0420","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1038\/s41419-018-1011-1","article-title":"The novel immunoglobulin super family receptor SLAMF9 identified in TAM of murine and human melanoma influences pro-inflammatory cytokine secretion and migration","volume":"9","author":"Dollt","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.clim.2025.110574_bb0425","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1016\/j.cell.2024.04.003","article-title":"RNA aggregates harness the danger response for potent cancer immunotherapy","volume":"187","author":"Mendez-Gomez","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.clim.2025.110574_bb0430","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.ccell.2020.09.004","article-title":"Immunometabolic interplay in the tumor microenvironment","volume":"39","author":"Kaymak","year":"2021","journal-title":"Cancer Cell"},{"key":"10.1016\/j.clim.2025.110574_bb0435","doi-asserted-by":"crossref","first-page":"4063","DOI":"10.1182\/blood-2004-04-1273","article-title":"The adaptor protein SH2D1A regulates signaling through CD150 (SLAM) in B cells","volume":"104","author":"Mikhalap","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.clim.2025.110574_bb0440","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0185940","article-title":"The interplay of CD150 and CD180 receptor pathways contribute to the pathobiology of chronic lymphocytic leukemia B cells by selective inhibition of Akt and MAPK signaling","volume":"12","author":"Gordiienko","year":"2017","journal-title":"PloS One"},{"key":"10.1016\/j.clim.2025.110574_bb0445","doi-asserted-by":"crossref","first-page":"24621","DOI":"10.18632\/oncotarget.15600","article-title":"LMP1+SLAMF1high cells are associated with drug resistance in Epstein-Barr virus-positive Farage cells","volume":"8","author":"Yoon","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.clim.2025.110574_bb0450","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13215451","article-title":"New look of EBV LMP1 signaling landscape","volume":"13","author":"Wang","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.clim.2025.110574_bb0455","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s12943-023-01725-x","article-title":"Roles of tumor-associated macrophages in anti-PD-1\/PD-L1 immunotherapy for solid cancers","volume":"22","author":"Zhang","year":"2023","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.clim.2025.110574_bb0460","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1177\/0022034517712435","article-title":"STAT3 induces immunosuppression by upregulating PD-1\/PD-L1 in HNSCC","volume":"96","author":"Bu","year":"2017","journal-title":"J. Dent. Res."},{"key":"10.1016\/j.clim.2025.110574_bb0465","article-title":"Migration of myeloid cells during inflammation is differentially regulated by the cell surface receptors Slamf1 and Slamf8","volume":"10","author":"Wang","year":"2015","journal-title":"PloS One"},{"key":"10.1016\/j.clim.2025.110574_bb0470","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1002\/JLB.4MA0820-655RR","article-title":"SLAMF1 signaling induces Mycobacterium tuberculosis uptake leading to endolysosomal maturation in human macrophages","volume":"109","author":"Barbero","year":"2021","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.clim.2025.110574_bb0475","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1084\/jem.177.5.1439","article-title":"A soluble multimeric recombinant CD2 protein identifies CD48 as a low affinity ligand for human CD2: divergence of CD2 ligands during the evolution of humans and mice","volume":"177","author":"Arulanandam","year":"1993","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.clim.2025.110574_bb0480","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1006\/scbi.2001.0398","article-title":"Tumor cell recognition by natural killer cells","volume":"12","author":"Long","year":"2002","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.clim.2025.110574_bb0485","doi-asserted-by":"crossref","first-page":"8886","DOI":"10.1158\/0008-5472.CAN-09-2687","article-title":"Recognition and killing of brain tumor stem-like initiating cells by CD8+ cytolytic T cells","volume":"69","author":"Brown","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.clim.2025.110574_bb0490","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/nri3862","article-title":"Molecular and cellular insights into T cell exhaustion","volume":"15","author":"Wherry","year":"2015","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.clim.2025.110574_bb0495","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1002\/hep.26192","article-title":"Monocyte\/macrophage-elicited natural killer cell dysfunction in hepatocellular carcinoma is mediated by CD48\/2B4 interactions","volume":"57","author":"Wu","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.clim.2025.110574_bb0500","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.coi.2019.04.014","article-title":"Heterogeneity and fate choice: T cell exhaustion in cancer and chronic infections","volume":"58","author":"Philip","year":"2019","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.clim.2025.110574_bb0505","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/ni.2035","article-title":"T cell exhaustion","volume":"12","author":"Wherry","year":"2011","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.clim.2025.110574_bb0510","article-title":"SLAMF3 and SLAMF4 are immune checkpoints that constrain macrophage phagocytosis of hematopoietic tumors","volume":"7","author":"Li","year":"2022","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.clim.2025.110574_bb0515","doi-asserted-by":"crossref","first-page":"291","DOI":"10.4049\/jimmunol.176.1.291","article-title":"Ly9 (CD229)-deficient mice exhibit T cell defects yet do not share several phenotypic characteristics associated with SLAM- and SAP-deficient mice","volume":"176","author":"Graham","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2025.110574_bb0520","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1158\/1541-7786.MCR-19-0391","article-title":"SLAMF3-mediated signaling via ERK pathway activation promotes aggressive phenotypic behaviors in multiple myeloma","volume":"18","author":"Ishibashi","year":"2020","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.clim.2025.110574_bb0525","doi-asserted-by":"crossref","first-page":"4393","DOI":"10.1182\/blood-2023-184362","article-title":"CD84 (SLAMF5) as a potential target for immunomodulation in cutaneous T-cell lymphoma (CTCL)","volume":"142","author":"Gunes","year":"2023","journal-title":"Blood"},{"key":"10.1016\/j.clim.2025.110574_bb0530","doi-asserted-by":"crossref","first-page":"5465","DOI":"10.1172\/JCI96610","article-title":"CD84 regulates PD-1\/PD-L1 expression and function in chronic lymphocytic leukemia","volume":"128","author":"Lewinsky","year":"2018","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.clim.2025.110574_bb0535","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1158\/2326-6066.CIR-18-0664","article-title":"SLAMF6 as a regulator of exhausted CD8(+) T cells in cancer","volume":"7","author":"Yigit","year":"2019","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.clim.2025.110574_bb0540","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.774244","article-title":"A novel immune and stroma related prognostic marker for invasive breast cancer in tumor microenvironment: a TCGA based study","volume":"12","author":"Huang","year":"2021","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.clim.2025.110574_bb0545","article-title":"Effect of SLAMF8 on the phagocytosis of tumor-associated macrophages in colorectal cancer","volume":"42","author":"Zhang","year":"2024","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.clim.2025.110574_bb0550","doi-asserted-by":"crossref","DOI":"10.1016\/j.imlet.2025.106990","article-title":"SLAMF8 regulates Fc receptor-mediated phagocytosis in mouse macrophage cells through PI3K-Akt signaling","volume":"273","author":"Liu","year":"2025","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.clim.2025.110574_bb0555","doi-asserted-by":"crossref","first-page":"17899","DOI":"10.1038\/s41598-024-68134-y","article-title":"The prognostic and immune significance of SLAMF9 in pan-cancer and validation of its role in colorectal cancer","volume":"14","author":"Zhao","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.clim.2025.110574_bb0560","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.114920","article-title":"CD84 as a therapeutic target for breaking immune tolerance in triple-negative breast cancer","volume":"43","author":"Rabani","year":"2024","journal-title":"Cell Rep."},{"key":"10.1016\/j.clim.2025.110574_bb0565","doi-asserted-by":"crossref","first-page":"7891","DOI":"10.3390\/curroncol30090573","article-title":"SLAMF7 as a promising immunotherapeutic target in multiple myeloma treatments","volume":"30","author":"Chu","year":"2023","journal-title":"Curr. Oncol."},{"key":"10.1016\/j.clim.2025.110574_bb0570","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2023-008769","article-title":"Preclinical activity of allogeneic SLAMF7-specific CAR T-cells (UCARTCS1) in multiple myeloma","volume":"12","author":"Korst","year":"2024","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.clim.2025.110574_bb0575","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1172\/JCI83013","article-title":"SLAMF1 regulation of chemotaxis and autophagy determines CLL patient response","volume":"126","author":"Bologna","year":"2016","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.clim.2025.110574_bb0580","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1172\/JCI24176","article-title":"Chronic lymphocytic leukemia cells induce changes in gene expression of CD4 and CD8 T cells","volume":"115","author":"G\u00f6rg\u00fcn","year":"2005","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.clim.2025.110574_bb0585","doi-asserted-by":"crossref","first-page":"760","DOI":"10.4149\/neo_2021_210104N8","article-title":"CD150 and CD180 are negative regulators of IL-10 expression and secretion in chronic lymphocytic leukemia B cells","volume":"68","author":"Shcherbina","year":"2021","journal-title":"Neoplasma"},{"key":"10.1016\/j.clim.2025.110574_bb0590","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.4049\/jimmunol.1401329","article-title":"B10 cells: a functionally defined regulatory B cell subset","volume":"194","author":"Tedder","year":"2015","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2025.110574_bb0595","article-title":"Single-cell transcriptomic landscape reveals tumor specific innate lymphoid cells associated with colorectal cancer progression","volume":"2","author":"Qi","year":"2021","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.clim.2025.110574_bb0600","doi-asserted-by":"crossref","first-page":"354","DOI":"10.3892\/ol.2024.14487","article-title":"Comprehensive analysis of signaling lymphocyte activation molecule family as a prognostic biomarker and correlation with immune infiltration in clear cell renal cell carcinoma","volume":"28","author":"Song","year":"2024","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.clim.2025.110574_bb0605","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s12185-019-02649-3","article-title":"Expression analysis of two SLAM family receptors, SLAMF2 and SLAMF7, in patients with multiple myeloma","volume":"110","author":"Ashour","year":"2019","journal-title":"Int. J. Hematol."},{"key":"10.1016\/j.clim.2025.110574_bb0610","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0082918","article-title":"Identification of SLAMF3 (CD229) as an inhibitor of hepatocellular carcinoma cell proliferation and tumour progression","volume":"8","author":"Marcq","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.clim.2025.110574_bb0615","doi-asserted-by":"crossref","first-page":"9832","DOI":"10.18632\/oncotarget.6954","article-title":"RB\/PLK1-dependent induced pathway by SLAMF3 expression inhibits mitosis and control hepatocarcinoma cell proliferation","volume":"7","author":"Bouhlal","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.clim.2025.110574_bb0620","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14040910","article-title":"Rescuing SLAMF3 expression restores Sorafenib response in hepatocellular carcinoma cells through the induction of mesenchymal-to-epithelial transition","volume":"14","author":"Fouquet","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.clim.2025.110574_bb0625","doi-asserted-by":"crossref","first-page":"3668","DOI":"10.4049\/jimmunol.167.7.3668","article-title":"CD84 functions as a homophilic adhesion molecule and enhances IFN-gamma secretion: adhesion is mediated by Ig-like domain 1","volume":"167","author":"Martin","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2025.110574_bb0630","doi-asserted-by":"crossref","first-page":"62","DOI":"10.3389\/fimmu.2018.00062","article-title":"Signaling lymphocyte activation molecule family 5 enhances autophagy and fine-tunes cytokine response in monocyte-derived dendritic cells via stabilization of interferon regulatory factor 8","volume":"9","author":"Agod","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.clim.2025.110574_bb0635","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1038\/onc.2016.238","article-title":"CD84 mediates CLL-microenvironment interactions","volume":"36","author":"Marom","year":"2017","journal-title":"Oncogene"},{"key":"10.1016\/j.clim.2025.110574_bb0640","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.173312","article-title":"CD84 is a regulator of the immunosuppressive microenvironment in multiple myeloma","volume":"8","author":"Lewinsky","year":"2023","journal-title":"JCI Insight"},{"key":"10.1016\/j.clim.2025.110574_bb0645","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1002\/JLB.6MA0822-720RR","article-title":"Single-cell phenotypic profiling to identify a set of immune cell protein biomarkers for relapsed and refractory diffuse large B cell lymphoma: a single-center study","volume":"112","author":"Shi","year":"2022","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.clim.2025.110574_bb0650","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.1038\/s41598-023-50062-y","article-title":"Clinical and immunological relevance of SLAMF6 expression in the tumor microenvironment of breast cancer and melanoma","volume":"14","author":"Oba","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.clim.2025.110574_bb0655","doi-asserted-by":"crossref","DOI":"10.3802\/jgo.2024.35.e79","article-title":"SLAMF7 predicts prognosis and correlates with immune infiltration in serous ovarian carcinoma","volume":"35","author":"Deng","year":"2024","journal-title":"J. Gynecol. Oncol."},{"key":"10.1016\/j.clim.2025.110574_bb0660","doi-asserted-by":"crossref","first-page":"8944","DOI":"10.18632\/aging.205850","article-title":"SLAMF8 can predict prognosis of pan-cancer and the immunotherapy response effectivity of gastric cancer","volume":"16","author":"Li","year":"2024","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.clim.2025.110574_bb0665","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.4049\/jimmunol.2100819","article-title":"SLAMF1 is dispensable for vaccine-induced T cell development but required for resistance to fungal infection","volume":"208","author":"Kohn","year":"2022","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2025.110574_bb0670","doi-asserted-by":"crossref","first-page":"24895","DOI":"10.18632\/oncotarget.4366","article-title":"A measles virus selectively blind to signaling lymphocytic activation molecule shows anti-tumor activity against lung cancer cells","volume":"6","author":"Fujiyuki","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.clim.2025.110574_bb0675","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/S0140-6736(71)90869-5","article-title":"Possible effect of measles on leukaemia","volume":"1","author":"Pasquinucci","year":"1971","journal-title":"Lancet"},{"key":"10.1016\/j.clim.2025.110574_bb0680","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0140-6736(71)92086-1","article-title":"Regression of Burkitt\u2019s lymphoma in association with measles infection","volume":"2","author":"Bluming","year":"1971","journal-title":"Lancet"},{"key":"10.1016\/j.clim.2025.110574_bb0685","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1182\/blood-2012-09-457531","article-title":"T cells from CLL patients exhibit features of T-cell exhaustion but retain capacity for cytokine production","volume":"121","author":"Riches","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.clim.2025.110574_bb0690","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1158\/1078-0432.CCR-11-2630","article-title":"Expansion of a CD8(+)PD-1(+) replicative senescence phenotype in early stage CLL patients is associated with inverted CD4:CD8 ratios and disease progression","volume":"18","author":"Nunes","year":"2012","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.clim.2025.110574_bb0695","doi-asserted-by":"crossref","first-page":"E2480","DOI":"10.1073\/pnas.1305394110","article-title":"Strength of PD-1 signaling differentially affects T-cell effector functions","volume":"110","author":"Wei","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.clim.2025.110574_bb0700","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.it.2015.02.008","article-title":"Overcoming T cell exhaustion in infection and cancer","volume":"36","author":"Pauken","year":"2015","journal-title":"Trends Immunol."},{"key":"10.1016\/j.clim.2025.110574_bb0705","doi-asserted-by":"crossref","first-page":"460","DOI":"10.21147\/j.issn.1000-9604.2022.05.07","article-title":"Myeloid checkpoints for cancer immunotherapy","volume":"34","author":"Qian","year":"2022","journal-title":"Chin. J. Cancer Res."},{"key":"10.1016\/j.clim.2025.110574_bb0710","doi-asserted-by":"crossref","first-page":"E2776","DOI":"10.1073\/pnas.1620498114","article-title":"Exhaustion-associated regulatory regions in CD8(+) tumor-infiltrating T cells","volume":"114","author":"Mognol","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.clim.2025.110574_bb0715","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2019-000245","article-title":"CD244 represents a new therapeutic target in head and neck squamous cell carcinoma","volume":"8","author":"Agresta","year":"2020","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.clim.2025.110574_bb0720","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.clim.2016.01.008","article-title":"Roles of CD48 in regulating immunity and tolerance","volume":"164","author":"McArdel","year":"2016","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.clim.2025.110574_bb0725","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1182\/bloodadvances.2017004382","article-title":"PD-1 blockade enhances elotuzumab efficacy in mouse tumor models","volume":"1","author":"Bezman","year":"2017","journal-title":"Blood Adv."},{"key":"10.1016\/j.clim.2025.110574_bb0730","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/cns.13041","article-title":"Costimulatory checkpoint SLAMF8 is an independent prognosis factor in glioma","volume":"25","author":"Zou","year":"2019","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.clim.2025.110574_bb0735","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s12931-024-03093-6","article-title":"Signatures of H3K4me3 modification predict cancer immunotherapy response and identify a new immune checkpoint-SLAMF9","volume":"26","author":"Fan","year":"2025","journal-title":"Respir. Res."},{"key":"10.1016\/j.clim.2025.110574_bb0740","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.3389\/fimmu.2018.02431","article-title":"Update on PD-1\/PD-L1 inhibitors in multiple myeloma","volume":"9","author":"Jelinek","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.clim.2025.110574_bb0745","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s40164-023-00456-5","article-title":"Immune checkpoint inhibitors for multiple myeloma immunotherapy","volume":"12","author":"Liu","year":"2023","journal-title":"Exp. Hematol. Oncol."},{"key":"10.1016\/j.clim.2025.110574_bb0750","doi-asserted-by":"crossref","first-page":"307","DOI":"10.2147\/CMAR.S117477","article-title":"Emerging combination therapies for the management of multiple myeloma: the role of elotuzumab","volume":"9","author":"Chen","year":"2017","journal-title":"Cancer Manag. Res."},{"key":"10.1016\/j.clim.2025.110574_bb0755","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1056\/NEJMoa1200690","article-title":"Safety, activity, and immune correlates of anti-PD-1 antibody in cancer","volume":"366","author":"Topalian","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.clim.2025.110574_bb0760","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1182\/blood-2017-07-740993","article-title":"PD-1 expression and clinical PD-1 blockade in B-cell lymphomas","volume":"131","author":"Xu-Monette","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.clim.2025.110574_bb0765","doi-asserted-by":"crossref","first-page":"34784","DOI":"10.18632\/oncotarget.26196","article-title":"Clinical impact of serum soluble SLAMF7 in multiple myeloma","volume":"9","author":"Ishibashi","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.clim.2025.110574_bb0770","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1080\/1744666X.2016.1209112","article-title":"The role of SLAMF7 in multiple myeloma: impact on therapy","volume":"13","author":"Boudreault","year":"2017","journal-title":"Expert Rev. Clin. Immunol."},{"key":"10.1016\/j.clim.2025.110574_bb0775","doi-asserted-by":"crossref","first-page":"3431","DOI":"10.1182\/blood.V124.21.3431.3431","article-title":"Dissecting the mechanisms of activity of SLAMF7 and the targeting antibody elotuzumab in multiple myeloma","volume":"124","author":"Glavey","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.clim.2025.110574_bb0780","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1182\/blood-2015-10-646810","article-title":"Clinical efficacy and management of monoclonal antibodies targeting CD38 and SLAMF7 in multiple myeloma","volume":"127","author":"van de Donk","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.clim.2025.110574_bb0785","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.3389\/fimmu.2018.02551","article-title":"Mechanisms of NK cell activation and clinical activity of the therapeutic SLAMF7 antibody, elotuzumab in multiple myeloma","volume":"9","author":"Campbell","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.clim.2025.110574_bb0790","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1001\/jama.2022.0003","article-title":"Diagnosis and management of multiple myeloma: a review","volume":"327","author":"Cowan","year":"2022","journal-title":"Jama"},{"key":"10.1016\/j.clim.2025.110574_bb0795","first-page":"1637","article-title":"CS1 (SLAMF7, CD319) is an effective immunotherapeutic target for multiple myeloma","volume":"7","author":"Malaer","year":"2017","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.clim.2025.110574_bb0800","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.1182\/blood-2016-01-694604","article-title":"Randomized phase 2 study: elotuzumab plus bortezomib\/dexamethasone vs bortezomib\/dexamethasone for relapsed\/refractory MM","volume":"127","author":"Jakubowiak","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.clim.2025.110574_bb0805","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1080\/10428194.2024.2385501","article-title":"Post-ASCT consolidation with elotuzumab, lenalidomide, and dexamethasone or elotuzumab, pomalidomide, and dexamethasone in high-risk and ultra-high-risk multiple myeloma: a retrospective single-center study","volume":"65","author":"Zolotov","year":"2024","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.clim.2025.110574_bb0810","doi-asserted-by":"crossref","first-page":"809","DOI":"10.2217\/imt-2016-0001","article-title":"Immune checkpoint blockade in human cancer therapy: lung cancer and hematologic malignancies","volume":"8","author":"Janakiram","year":"2016","journal-title":"Immunotherapy"},{"key":"10.1016\/j.clim.2025.110574_bb0815","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1007\/s00262-017-1961-7","article-title":"Novel B7-H4-mediated crosstalk between human non-Hodgkin lymphoma cells and tumor-associated macrophages leads to immune evasion via secretion of IL-6 and IL-10","volume":"66","author":"Che","year":"2017","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.clim.2025.110574_bb0820","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2020.153114","article-title":"Immune checkpoint inhibitors in multiple myeloma: a review of the literature","volume":"216","author":"Caserta","year":"2020","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.clim.2025.110574_bb0825","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1158\/2326-6066.CIR-20-0800","article-title":"Alternative splicing of the inhibitory immune checkpoint receptor SLAMF6 generates a dominant positive form, boosting T-cell effector functions","volume":"9","author":"Hajaj","year":"2021","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.clim.2025.110574_bb0830","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0093523","article-title":"Phenotypic T cell exhaustion in a murine model of bacterial infection in the setting of pre-existing malignancy","volume":"9","author":"Mittal","year":"2014","journal-title":"PloS One"},{"key":"10.1016\/j.clim.2025.110574_bb0835","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15194808","article-title":"SLAM modification as an immune-modulatory therapeutic approach in cancer","volume":"15","author":"Tojjari","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.clim.2025.110574_bb0840","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0218109","article-title":"SLAMF6 clustering is required to augment T cell activation","volume":"14","author":"Dragovich","year":"2019","journal-title":"PloS One"},{"key":"10.1016\/j.clim.2025.110574_bb0845","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1002\/eji.202149406","article-title":"SLAMF7 selectively favors degranulation to promote cytotoxicity in human NK cells","volume":"52","author":"Gutierrez-Guerrero","year":"2022","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.clim.2025.110574_bb0850","doi-asserted-by":"crossref","first-page":"30779","DOI":"10.1038\/s41598-024-80971-5","article-title":"SLAMF7 defines subsets of human effector CD8 T cells","volume":"14","author":"Kared","year":"2024","journal-title":"Sci. Rep."}],"container-title":["Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661625001494?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661625001494?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T18:41:48Z","timestamp":1759862508000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521661625001494"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":170,"alternative-id":["S1521661625001494"],"URL":"https:\/\/doi.org\/10.1016\/j.clim.2025.110574","relation":{},"ISSN":["1521-6616"],"issn-type":[{"value":"1521-6616","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of signaling lymphocytic activation molecule (SLAM) family receptors in health and disease progression: Focusing on cancer and therapy","name":"articletitle","label":"Article Title"},{"value":"Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clim.2025.110574","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110574"}}